| Anti-SSTR2 antibody-drug conjugate for neuroendocrine tumor therapy Y Si, S Kim, J Ou, Y Lu, P Ernst, K Chen, J Whitt, AM Carter, JM Markert, ... Cancer gene therapy 28 (7), 799-812, 2021 | 40 | 2021 |
| Process engineering of cellulosic n-butanol production from corn-based biomass using Clostridium cellulovorans J Ou, N Xu, P Ernst, C Ma, M Bush, KY Goh, J Zhao, L Zhou, ST Yang, ... Process Biochemistry 62, 144-150, 2017 | 36 | 2017 |
| Bioprocess development of antibody-drug conjugate production for cancer treatment J Ou, Y Si, KY Goh, N Yasui, Y Guo, J Song, L Wang, R Jaskula-Sztul, ... PloS one 13 (10), e0206246, 2018 | 30 | 2018 |
| Bioreactor suspension culture: differentiation and production of cardiomyocyte spheroids from human induced pluripotent stem cells A Kahn-Krell, D Pretorius, J Ou, VG Fast, S Litovsky, J Berry, X Liu, ... Frontiers in bioengineering and biotechnology 9, 674260, 2021 | 25 | 2021 |
| High butanol production by regulating carbon, redox and energy in Clostridia J Ou, C Ma, N Xu, Y Du, X Liu Frontiers of Chemical Science and Engineering 9, 317-323, 2015 | 25 | 2015 |
| Establishing a co-culture system for Clostridium cellulovorans and Clostridium aceticum for high efficiency biomass transformation D Xia, AK Alexander, A Isbell, S Zhang, J Ou, XM Liu J. Sci. Heal. Univ. Ala 14, 8-13, 2017 | 20 | 2017 |
| Novel biomanufacturing platform for large-scale and high-quality human T cells production J Ou, Y Si, Y Tang, GE Salzer, Y Lu, S Kim, H Qin, L Zhou, X Liu Journal of Biological Engineering 13, 1-13, 2019 | 19 | 2019 |
| Rebalancing Redox to Improve Biobutanol Production by Clostridium tyrobutyricum C Ma, J Ou, N Xu, JL Fierst, ST Yang, X Liu Bioengineering 3 (1), 2, 2015 | 18 | 2015 |
| Development of a quantitative real‐time PCR assay for direct detection of growth of cellulose‐degrading bacterium Clostridium thermocellum in lignocellulosic … H Tang, JF Ou, MJ Zhu Journal of Applied Microbiology 118 (6), 1333-1344, 2015 | 17 | 2015 |
| An overview of current and novel approaches for microbial neutral protease improvement JF Ou, MJ Zhu Int. J. Mod. Biol. Med 2 (1), 1-31, 2012 | 14 | 2012 |
| Proteomics insight into the production of monoclonal antibody N Xu, J Ou, Y Si, KY Goh, DD Flanigan, X Han, Y Yang, ST Yang, L Zhou, ... Biochemical Engineering Journal 145, 177-185, 2019 | 12 | 2019 |
| High production of butyric acid by Clostridium tyrobutyricum mutant C Ma, J Ou, M Miller, S McFann, X Liu Frontiers of Chemical Science and Engineering 9, 369-375, 2015 | 12 | 2015 |
| Antibody–Drug Conjugate to Treat Meningiomas K Chen, Y Si, J Ou, JS Guan, S Kim, P Ernst, Y Zhang, L Zhou, X Han, ... Pharmaceuticals 14 (5), 427, 2021 | 9 | 2021 |
| Intracellular metabolism analysis of Clostridium cellulovorans via modeling integrating proteomics, metabolomics and fermentation J Ou, T Bao, P Ernst, Y Si, SD Prabhu, H Wu, JJ Zhang, L Zhou, ST Yang, ... Process Biochemistry 89, 9-19, 2020 | 9 | 2020 |
| High-level expression of recombinant IgG1 by CHO K1 platform N Xu, J Ou, AK Gilani, L Zhou, M Liu Frontiers of Chemical Science and Engineering 9, 376-380, 2015 | 9 | 2015 |
| A growth model of neuroendocrine tumor surrogates and the efficacy of a novel somatostatin-receptor–guided antibody-drug conjugate: Perspectives on clinical response? B Herring, J Whitt, T Aweda, J Ou, R Guenter, S Lapi, J Berry, H Chen, ... Surgery 167 (1), 197-203, 2020 | 4 | 2020 |
| 中性蛋白酶高产菌株的诱变选育 朱明军， 区健发， 陈鸿图 现代食品科技 29 (11), 2686-2691, 2013 | 3 | 2013 |
| 2018 Synaptic vesicle 2 receptors as a novel targets for neuroendocrine cancer therapy R Jaskula-Sztul, JD Whitt, J Ou, MX Liu, Z Aburjania, H Chen Journal of Clinical and Translational Science 2 (S1), 28-29, 2018 | 1 | 2018 |
| A Computational Modeling to Integrate Multi-Omics in Clostridium cellulovorans to Guide Metabolic Engineering J Ou, N Xu, C Ma, P Ernst, X Liu 2017 AIChE Annual Meeting, 2017 | 1 | 2017 |
| Neuroendocrine cancer targeted therapy X Liu, L Zhou, J Ou, Y Si, R Jaskula-Sztul, H Chen, JD Whitt, J Zhang US Patent 12,156,918, 2024 | | 2024 |